Pyrimidine 5′ Nucleotidase Deficiency

D. Rees,J. Duley,A. Marinaki

DOI: https://doi.org/10.1046/j.1365-2141.2003.03980.x

2003-02-01

British Journal of Haematology

Abstract:P5¢N-1, also known as uridine monophosphate hydrolase-1 (UMPH-1), is a member of a large functional group of enzymes, characterized by the ability to dephosphorylate nucleic acids (Paglia & Valentine, 1980). Nucleotidase activity was first demonstrated more than 90 years ago in extracts of mammalian tissues, and lead to the description of acid and alkaline phosphatases (Levene & Medigreceanu, 1911). In the 1930s, 5¢ nucleotidases were first identified, shown to be widely distributed, and found to be equally active on purines and pyrimidines (Reis, 1940). P5¢N-1 was first identified in the early 1970s by William Valentine and co-workers in erythrocyte stroma, while investigating a patient with unexplained haemolysis (Valentine et al, 1972, 1973). The initial patient had a non-spherocytic haemolytic anaemia with a haemoglobin of 8–10 g ⁄ dl and marked basophilic stippling. There were no abnormalities of the Embden–Meyerhof pathway, pentose-phosphate shunt or glutathione pathways (Valentine et al, 1972, 1973) but biochemical analysis of the red cells showed an unexpectedly high level of what were thought to be adenine nucleotides, associated with high glutathione levels and reduced activity of ribose-phosphate pyrophosphokinase. The exact nature of the red cell defect was unclear, but studies on three further kindreds with haemolytic anaemia and basophilic stippling showed an autosomal recessive pattern of inheritance. It was also found that what were thought to be adenine nucleotides in the red cells were in fact pyrimidine nucleotides, which are normally undetectable. Further studies demonstrated pyrimidine 5¢ nucleotidase activity in normal red cells which was absent or markedly reduced in individuals with this form of haemolytic anaemia (Valentine et al, 1974). Thirty years have now passed since the first description of P5¢N-1 deficiency. There have been more than 40 further reports of the condition from all over the world and it has emerged as one of the commonest forms of congenital nonspherocytic haemolytic anaemia, once glucose-6-phosphate dehydrogenase (G6PD) and pyruvate kinase deficiencies have been excluded.